New Test Promises Quicker, More Accurate Evaluation For Cystic Fibrosis Patients

Researchers have identified a simple gene-based blood test that more accurately and quickly measures cystic fibrosis patients' response to therapy than current tests. The test, a measure of inflammatory gene expression, could improve patient care and help clear a backlog of promising medications now hung up in clinical trials.

Read the whole article on Science Daily

More from Science Daily